{"id":471378,"date":"2021-04-06T06:58:21","date_gmt":"2021-04-06T10:58:21","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=471378"},"modified":"2021-04-06T06:58:21","modified_gmt":"2021-04-06T10:58:21","slug":"volastra-therapeutics-partners-with-microsoft-to-advance-metastatic-cancer-research","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/volastra-therapeutics-partners-with-microsoft-to-advance-metastatic-cancer-research\/","title":{"rendered":"Volastra Therapeutics Partners with Microsoft to Advance Metastatic Cancer Research"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position:inside; }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Volastra Therapeutics Partners with Microsoft to Advance Metastatic Cancer Research<\/b><\/p>\n<p class=\"bwalignc\"><i>Collaboration will integrate Microsoft Azure AI and Volastra\u2019s insights into tumor biology to develop machine learning tools to detect drivers of tumor growth and predict metastatic risk<\/i><\/p>\n<p>NEW YORK&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.volastratx.com%2F&amp;esheet=52405779&amp;newsitemid=20210406005268&amp;lan=en-US&amp;anchor=Volastra+Therapeutics&amp;index=1&amp;md5=002ecfd800eb5d61ef055eeb41e4f7d7\">Volastra Therapeutics<\/a> today announced it will collaborate with Microsoft to develop tools that help detect drivers of cancer metastasis. These unique digital pathology tools will accelerate the development of promising new therapies for cancer and help identify the patients most likely to benefit.\n<\/p>\n<p>\n\u201cMetastasis is one of the biggest unsolved challenges in cancer treatment, but new insights into tumor biology from our founders have laid the groundwork for major advancements in this field,\u201d said Charles Hugh-Jones, M.D., Chief Executive Officer at Volastra. \u201cWe are excited to work with Microsoft to apply data science to the challenges of cancer research. The digital tools we develop will fuel our drug discovery efforts and bring new hope to people living with cancer.\u201d\n<\/p>\n<p>\n\u201cWe have seen the tremendous promise of advanced computation in the fields of medical diagnostics and drug discovery,\u201d said Desney Tan, Ph.D., Managing Director, Microsoft Health Futures. \u201cThe collaboration with Volastra will lead to potential advances in the development of therapies to prevent and treat cancer metastasis. We look forward to continued collaboration with Volastra to deliver solutions for the computational life sciences community.\u201d\n<\/p>\n<p>\nThe teams will work together on algorithms to identify markers that correlate with tumor metastatic behaviors. The collaboration will develop automated machine learning tools capable of rapidly and accurately integrating insights across multiple datasets, including pathology slides and three-dimensional tumor-derived organoids.\n<\/p>\n<p><b>About Volastra Therapeutics, Inc.<\/b><\/p>\n<p>\nVolastra Therapeutics is pioneering novel approaches to halt or prevent cancer metastasis, one of the major unsolved challenges in cancer treatment. Co-founders Lewis Cantley, Ph.D., Olivier Elemento, Ph.D. and Samuel Bakhoum, M.D., Ph.D., made seminal discoveries about the role of chromosomal instability in driving cancer spread. Volastra is built on those insights. Based in West Harlem, N.Y., Volastra is committed to improving outcomes for people living with cancer. For more information, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.volastratx.com%2F&amp;esheet=52405779&amp;newsitemid=20210406005268&amp;lan=en-US&amp;anchor=volastratx.com&amp;index=2&amp;md5=b776364af929e2b8d11439f2e1f92013\">volastratx.com<\/a>.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210406005268r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210406005268\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210406005268\/en\/<\/a><\/span><\/p>\n<p>\nLisa Qu<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:lqu@tenbridgecommunications.com\">lqu@tenbridgecommunications.com<br \/>\n<\/a><br \/>678-662-9166\n<\/p>\n<p><b>KEYWORDS:<\/b> United States North America New York<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Health Science Research Oncology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210406005268\/en\/868953\/3\/FinalVolastraLogo2_RGB_Foundry._Sterling_Light_copy.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Volastra Therapeutics Partners with Microsoft to Advance Metastatic Cancer Research Collaboration will integrate Microsoft Azure AI and Volastra\u2019s insights into tumor biology to develop machine learning tools to detect drivers of tumor growth and predict metastatic risk NEW YORK&#8211;(BUSINESS WIRE)&#8211;Volastra Therapeutics today announced it will collaborate with Microsoft to develop tools that help detect drivers of cancer metastasis. These unique digital pathology tools will accelerate the development of promising new therapies for cancer and help identify the patients most likely to benefit. \u201cMetastasis is one of the biggest unsolved challenges in cancer treatment, but new insights into tumor biology from our founders have laid the groundwork for major advancements in this field,\u201d said Charles Hugh-Jones, M.D., Chief Executive Officer at &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/volastra-therapeutics-partners-with-microsoft-to-advance-metastatic-cancer-research\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Volastra Therapeutics Partners with Microsoft to Advance Metastatic Cancer Research&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-471378","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Volastra Therapeutics Partners with Microsoft to Advance Metastatic Cancer Research - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/volastra-therapeutics-partners-with-microsoft-to-advance-metastatic-cancer-research\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Volastra Therapeutics Partners with Microsoft to Advance Metastatic Cancer Research - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Volastra Therapeutics Partners with Microsoft to Advance Metastatic Cancer Research Collaboration will integrate Microsoft Azure AI and Volastra\u2019s insights into tumor biology to develop machine learning tools to detect drivers of tumor growth and predict metastatic risk NEW YORK&#8211;(BUSINESS WIRE)&#8211;Volastra Therapeutics today announced it will collaborate with Microsoft to develop tools that help detect drivers of cancer metastasis. These unique digital pathology tools will accelerate the development of promising new therapies for cancer and help identify the patients most likely to benefit. \u201cMetastasis is one of the biggest unsolved challenges in cancer treatment, but new insights into tumor biology from our founders have laid the groundwork for major advancements in this field,\u201d said Charles Hugh-Jones, M.D., Chief Executive Officer at &hellip; Continue reading &quot;Volastra Therapeutics Partners with Microsoft to Advance Metastatic Cancer Research&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/volastra-therapeutics-partners-with-microsoft-to-advance-metastatic-cancer-research\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-06T10:58:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210406005268r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volastra-therapeutics-partners-with-microsoft-to-advance-metastatic-cancer-research\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volastra-therapeutics-partners-with-microsoft-to-advance-metastatic-cancer-research\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Volastra Therapeutics Partners with Microsoft to Advance Metastatic Cancer Research\",\"datePublished\":\"2021-04-06T10:58:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volastra-therapeutics-partners-with-microsoft-to-advance-metastatic-cancer-research\\\/\"},\"wordCount\":398,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volastra-therapeutics-partners-with-microsoft-to-advance-metastatic-cancer-research\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210406005268r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volastra-therapeutics-partners-with-microsoft-to-advance-metastatic-cancer-research\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volastra-therapeutics-partners-with-microsoft-to-advance-metastatic-cancer-research\\\/\",\"name\":\"Volastra Therapeutics Partners with Microsoft to Advance Metastatic Cancer Research - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volastra-therapeutics-partners-with-microsoft-to-advance-metastatic-cancer-research\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volastra-therapeutics-partners-with-microsoft-to-advance-metastatic-cancer-research\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210406005268r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-04-06T10:58:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volastra-therapeutics-partners-with-microsoft-to-advance-metastatic-cancer-research\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volastra-therapeutics-partners-with-microsoft-to-advance-metastatic-cancer-research\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volastra-therapeutics-partners-with-microsoft-to-advance-metastatic-cancer-research\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210406005268r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210406005268r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volastra-therapeutics-partners-with-microsoft-to-advance-metastatic-cancer-research\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Volastra Therapeutics Partners with Microsoft to Advance Metastatic Cancer Research\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Volastra Therapeutics Partners with Microsoft to Advance Metastatic Cancer Research - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/volastra-therapeutics-partners-with-microsoft-to-advance-metastatic-cancer-research\/","og_locale":"en_US","og_type":"article","og_title":"Volastra Therapeutics Partners with Microsoft to Advance Metastatic Cancer Research - Market Newsdesk","og_description":"Volastra Therapeutics Partners with Microsoft to Advance Metastatic Cancer Research Collaboration will integrate Microsoft Azure AI and Volastra\u2019s insights into tumor biology to develop machine learning tools to detect drivers of tumor growth and predict metastatic risk NEW YORK&#8211;(BUSINESS WIRE)&#8211;Volastra Therapeutics today announced it will collaborate with Microsoft to develop tools that help detect drivers of cancer metastasis. These unique digital pathology tools will accelerate the development of promising new therapies for cancer and help identify the patients most likely to benefit. \u201cMetastasis is one of the biggest unsolved challenges in cancer treatment, but new insights into tumor biology from our founders have laid the groundwork for major advancements in this field,\u201d said Charles Hugh-Jones, M.D., Chief Executive Officer at &hellip; Continue reading \"Volastra Therapeutics Partners with Microsoft to Advance Metastatic Cancer Research\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/volastra-therapeutics-partners-with-microsoft-to-advance-metastatic-cancer-research\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-06T10:58:21+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210406005268r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/volastra-therapeutics-partners-with-microsoft-to-advance-metastatic-cancer-research\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/volastra-therapeutics-partners-with-microsoft-to-advance-metastatic-cancer-research\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Volastra Therapeutics Partners with Microsoft to Advance Metastatic Cancer Research","datePublished":"2021-04-06T10:58:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/volastra-therapeutics-partners-with-microsoft-to-advance-metastatic-cancer-research\/"},"wordCount":398,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/volastra-therapeutics-partners-with-microsoft-to-advance-metastatic-cancer-research\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210406005268r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/volastra-therapeutics-partners-with-microsoft-to-advance-metastatic-cancer-research\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/volastra-therapeutics-partners-with-microsoft-to-advance-metastatic-cancer-research\/","name":"Volastra Therapeutics Partners with Microsoft to Advance Metastatic Cancer Research - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/volastra-therapeutics-partners-with-microsoft-to-advance-metastatic-cancer-research\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/volastra-therapeutics-partners-with-microsoft-to-advance-metastatic-cancer-research\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210406005268r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-04-06T10:58:21+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/volastra-therapeutics-partners-with-microsoft-to-advance-metastatic-cancer-research\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/volastra-therapeutics-partners-with-microsoft-to-advance-metastatic-cancer-research\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/volastra-therapeutics-partners-with-microsoft-to-advance-metastatic-cancer-research\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210406005268r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210406005268r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/volastra-therapeutics-partners-with-microsoft-to-advance-metastatic-cancer-research\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Volastra Therapeutics Partners with Microsoft to Advance Metastatic Cancer Research"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/471378","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=471378"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/471378\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=471378"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=471378"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=471378"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}